financetom
Business
financetom
/
Business
/
Lula slams US request for information on Brazil fighter jet deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lula slams US request for information on Brazil fighter jet deal
Oct 11, 2024 8:27 AM

SAO PAULO, Oct 11 (Reuters) - Brazilian President Luiz

Inacio Lula da Silva said on Friday it made "no sense" for the

U.S. Department of Justice to request information from Saab

over Brazil's purchase of the Swedish firm's Gripen

fighter jets in 2014.

Saab revealed the U.S. request on Thursday and said it

intended to comply, without providing further details, sending

its shares sliding.

"I think this is the U.S. meddling in another country's

affairs," Lula told a radio interview.

Lula is in the middle of his third non-consecutive term,

having previously served as president between 2003 and 2010.

The deal with Saab, which beat U.S. planemaker Boeing ( BA )

and France's Dassault to secure the contract, was inked

under Lula's handpicked successor, former President Dilma

Rousseff.

Brazilian prosecutors in 2016 formally accused Lula of using

his influence to help Saab win the tender for the 36 fighter

jets worth $5.4 billion. The case was tossed out by Brazil's

Supreme Court in 2022.

Saab said in its Thursday statement that Brazilian and

Swedish investigations into the procurement process had been

closed without indicating any wrongdoing by the firm.

Lula noted he initially intended to buy Dassault's Rafale

fighter, but left the decision to Rousseff as he only had a few

months left in his second term. He suggested the United States

was unhappy with Brazil's "sovereign" choice.

"They didn't like it when I said I was going to buy the

Rafale and certainly didn't like it when Dilma bought the

Swedish aircraft, as they wanted us to buy the U.S. plane," the

president said.

The agreement with Saab allowed Gripens to be produced in

Brazil. Last year, Saab and Embraer ( ERJ ) launched a

production line for the fighter at the Brazilian planemaker's

Gaviao Peixoto plant.

NEW PRESIDENTIAL PLANE

Lula also said he plans to buy a new presidential aircraft

after his 20-year-old Airbus A319 jet faced an

undisclosed technical problem this month during a flight from

Mexico City to Brasilia.

The plane encountered issues after departing the Mexican

capital and was forced to circle the area for hours to burn off

fuel before landing safely at the airport it had just departed.

Lula said one of the engines had issues and passengers felt

unusual vibrations.

"I have asked my defense minister to gather a proposal. We

will buy a presidential airplane and also some other aircraft

for ministers to travel on," he said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation
Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation
May 24, 2024
08:17 AM EDT, 05/24/2024 (MT Newswires) -- Organon (OGN) and Shanghai Henlius Biotech said Friday their marketing authorization applications for HLX14, a denosumab biosimilar, have been validated by the European Medicines Agency. The submissions were based on a phase 3 study comparing HLX14 with denosumab in postmenopausal women with osteoporosis, the companies said. Henlius licensed HLX14 to Organon in 2022...
E3 Lithium Narrows Q1 Loss; Company Hasn't Started Commercial Production or Generated Cash Flow
E3 Lithium Narrows Q1 Loss; Company Hasn't Started Commercial Production or Generated Cash Flow
May 24, 2024
08:25 AM EDT, 05/24/2024 (MT Newswires) -- E3 Lithium ( EEMMF ) on Friday reported a narrower loss for the first quarter even though the company has not generated revenues from operations and had an accumulated deficit of $45.2 million at the end of March. The company reported a first-quarter net loss of $2.4 million, or $0.03 per share, compared...
--Cato Keeps Quarterly Dividend at $0.17 per share, Payable June 24 to Shareholders of Record June 10
--Cato Keeps Quarterly Dividend at $0.17 per share, Payable June 24 to Shareholders of Record June 10
May 24, 2024
08:17 AM EDT, 05/24/2024 (MT Newswires) -- Price: 5.73, Change: -0.05, Percent Change: -0.87 ...
Verastem Reports Results of Potential Pancreatic Cancer Treatment, Submits Rolling New Drug Application for Rare Ovarian Cancer
Verastem Reports Results of Potential Pancreatic Cancer Treatment, Submits Rolling New Drug Application for Rare Ovarian Cancer
May 24, 2024
08:25 AM EDT, 05/24/2024 (MT Newswires) -- Verastem Oncology (VSTM) late Thursday reported that an ongoing phase 1/2 clinical trial evaluating avutometinib and defactinib in combination with gemcitabine and nab-paclitaxel in 41 patients with metastatic pancreatic cancer reached an interim partial response rate of 83%. Of 26 patients in all the trial cohorts who have had their first scan while...
Copyright 2023-2025 - www.financetom.com All Rights Reserved